Exagen [XGN] vs Danaher [DHR] Detailed Stock Comparison

Exagen Inc.

NASDAQ
Loading...

Danaher Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Exagen Inc. wins in 2 metrics, Danaher Corporation wins in 16 metrics, with 0 ties. Danaher Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Exagen Inc. Danaher Corporation Better
P/E Ratio (TTM) N/A 34.61 N/A
Price-to-Book Ratio 3.52 2.40 Danaher Corporation
Debt-to-Equity Ratio 158.55 37.17 Danaher Corporation
PEG Ratio -5.96 3.84 Danaher Corporation
EV/EBITDA -5.01 17.69 Danaher Corporation
Profit Margin (TTM) -29.97% 14.89% Danaher Corporation
Operating Margin (TTM) -29.91% 22.94% Danaher Corporation
EBITDA Margin (TTM) N/A 22.94% N/A
Return on Equity -147.85% 7.08% Danaher Corporation
Return on Assets (TTM) -17.12% 4.19% Danaher Corporation
Free Cash Flow (TTM) $-14.27M $5.26B Danaher Corporation
Dividend Yield N/A 0.56% N/A
1-Year Return -28.35% -3.81% Danaher Corporation
Price-to-Sales Ratio (TTM) 0.97 5.10 Exagen Inc.
Enterprise Value $59.91M $140.38B Danaher Corporation
EV/Revenue Ratio 0.90 5.67 Exagen Inc.
Gross Profit Margin (TTM) 55.35% 60.34% Danaher Corporation
Revenue per Share (TTM) $3 $35 Danaher Corporation
Earnings per Share (Diluted) $-0.93 $5.16 Danaher Corporation
Beta (Stock Volatility) 1.94 0.99 Danaher Corporation
Short % of Float 7.67% 1.10% Danaher Corporation

Exagen Inc. vs Danaher Corporation Stock Performance Analysis

Loading Price Chart...

XGN
DHR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Exagen Inc.-6.02%4.33%55.48%35.77%-32.11%-20.20%
Danaher Corporation1.12%1.91%1.19%-14.51%-22.28%-23.56%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Exagen Inc.-28.35%61.17%-62.64%-70.71%-70.71%-70.71%
Danaher Corporation-3.81%-12.18%-14.95%176.52%423.71%744.91%

Performance & Financial Health Analysis: Exagen Inc. vs Danaher Corporation

MetricXGNDHR
Market Information
Market Cap i$64.46M$126.39B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i206,1385,174,666
90 Day Avg. Volume i219,9294,357,215
Last Close$4.53$178.08
52 Week Range$2.59 - $12.23$160.93 - $242.80
% from 52W High-62.96%-26.66%
All-Time High$29.86 (Dec 23, 2019)$296.06 (Sep 06, 2021)
% from All-Time High-84.83%-39.85%
Growth Metrics
Quarterly Revenue Growth0.22%0.04%
Quarterly Earnings Growth0.22%0.08%
Financial Health
Profit Margin (TTM) i-0.30%0.15%
Operating Margin (TTM) i-0.30%0.23%
Return on Equity (TTM) i-1.48%0.07%
Debt to Equity (MRQ) i158.5537.17
Cash & Liquidity
Book Value per Share (MRQ)$0.76$74.32
Cash per Share (MRQ)$1.34$8.06
Operating Cash Flow (TTM) i$-13,625,000$6.44B
Levered Free Cash Flow (TTM) i$-10,364,500$4.57B
Dividends
Last 12-Month Dividend Yield iN/A0.56%
Last 12-Month Dividend iN/A$1.28

Valuation & Enterprise Metrics Analysis: Exagen Inc. vs Danaher Corporation

MetricXGN (Apr 24, 2026)DHR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) iN/A34.61
Forward P/E i-5.9619.64
PEG Ratio i-5.963.84
Price to Sales (TTM) i0.975.10
Price to Book (MRQ) i3.522.40
Market Capitalization
Market Capitalization i$64.46M$126.39B
Enterprise Value i$59.91M$140.38B
Enterprise Value Metrics
Enterprise to Revenue i0.905.67
Enterprise to EBITDA i-5.0117.69
Risk & Other Metrics
Beta i1.940.99
Book Value per Share (MRQ) i$0.76$74.32

Financial Statements Comparison: Exagen Inc. vs Danaher Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricXGN (2025)DHR (2025)
Revenue/Sales i66.58M24.57B
Cost of Goods Sold i27.78M10.05B
COGS % of Revenue i41.7%40.9%
Gross Profit i38.80M14.52B
Gross Margin i58.3%59.1%
Research & Development i6.25M1.60B
Operating Income (EBIT) i-14.07M4.69B
Operating Margin i-21.1%19.1%
EBITDA i-11.66M7.17B
EBITDA Margin i-17.5%29.2%
Pre-Tax Income i-19.90M4.23B
Pre-Tax Income % of Revenue i-29.9%17.2%
Income Tax i51,000633.00M
Income Tax % of Revenue i0.1%2.6%
Net Income (Profit) i-19.95M3.61B
Profit Margin i-30.0%14.7%

Balance Sheet & Liquidity Metrics

MetricXGN (2025)DHR (2025)
Cash & Equivalents i32.22M4.62B
Total Current Assets i48.89M12.76B
Total Current Assets % of Revenue i73.4%51.9%
Total Current Liabilities i14.16M6.81B
Total Current Liabilities % of Revenue i21.3%27.7%
Long-Term Debt i22.70M19.50B
Long-Term Debt % of Revenue i34.1%79.4%
Total Shareholders Equity i17.45M52.54B
Retained Earnings i-314.28M46.89B
Retained Earnings % of Revenue i-472.1%190.9%
Property, Plant & Equipment i9.67M2.14B

Cash Flow Statement Comparison

MetricXGN (2025)DHR (2025)
Operating Cash Flow i-16.79M5.64B
Operating Cash Flow % of Revenue i-25.2%23.0%
Capital Expenditures i-626,000-1.12B
Free Cash Flow i-14.27M5.26B
FCF Margin i-21.4%21.4%
Debt Repayment i-20.79M-500.00M
Common Stock Repurchase iN/A-3.09B

Short Interest & Institutional Ownership Analysis

MetricXGNDHR
Shares Short i1.53M6.94M
Short Ratio i4.901.68
Short % of Float i7.67%1.10%
Shares Outstanding i22.91M707.70M
Float Shares i16.17M630.65M
% Held by Insiders i18.09%10.78%
% Held by Institutions i59.71%85.08%
% Held by Public i22.20%4.14%

Dividend Analysis & Yield Comparison: Exagen Inc. vs Danaher Corporation

MetricXGNDHR
Last 12-Month Dividend iN/A$1.28
Last 12-Month Dividend Yield iN/A0.56%
3-Year Avg Annual Dividend iN/A$10.51
3-Year Avg Dividend Yield iN/A1.11%
3-Year Total Dividends iN/A$31.54
Ex-Dividend DateN/ADec 26, 2025